Ambu aScope 4 Broncho from Ambu A/ S - single-use scope aims for cleaner bronchoscopy

Reviewed: ad hoc news New Release & Launch desk. Edited and checked on 2026-06-30, 03:08. Details in the imprint.

The Ambu aScope 4 Broncho rests on a stainless trolley in an ICU bay, its slim disposable bronchoscope sealed in a clear pouch that crinkles when pulled open. The clinician feels the smooth plastic handle, knowing this scope will be used once and then thrown away.

What the aScope 4 does

The Ambu aScope 4 Broncho is a single-use flexible bronchoscope designed for airway inspection, secretion management and assisting in difficult intubations. It connects to a dedicated monitor or video system so staff see a live airway image within seconds of plugging it in.

Compared with reusable scopes, the aScope 4 Broncho is supplied sterile and disposed of after each procedure, which removes the need for reprocessing and the worry about residual contamination in narrow channels. That changes the workflow for nurses and biomedical technicians as much as for doctors.

How it feels in use

In practice, a clinician like Ambu test doctor Lars Petersen unwraps the bronchoscope, snaps the connector into the Ambu monitor and watches the screen flick from dark to a clean, bright image of vocal cords and trachea. There is no waiting for a reprocessed scope to come up from central sterile.

The shaft is thin and quite flexible, so it follows the natural curves of the upper airway without much resistance. At the same time, the handle gives a tactile, robust grip, so fine tip movements for biopsy or suction feel controlled rather than twitchy.

Why single-use matters

Ambu has spent years arguing that single-use endoscopy reduces cross-contamination risk by eliminating complex cleaning steps and repeated patient use. For infection-control committees, the idea of throwing away the bronchoscope after each case is a clear, consistent policy.

Reusable bronchoscopes, by contrast, rely on multi-step disinfection and drying cycles in dedicated washer-disinfectors. Any lapse in protocol or unnoticed damage in a channel can undermine that barrier, which is why Ambu CEO Britt Meelby Jensen keeps highlighting the hygiene angle in investor presentations.

Cost and logistics questions

For hospital managers, the aScope 4 Broncho does not remove cost pressure, it simply spreads it differently. Instead of capital expenditure on reusable stacks and reprocessors, procurement teams sign contracts for a higher volume of single-use scopes and monitor units.

That shifts the debate to per-procedure cost and overall utilisation. High-volume intensive care units may find predictable per-patient pricing convincing, while smaller centres must weigh stock expiry, storage space and how often they really reach for a bronchoscope in emergencies.

Integration into existing setups

The aScope 4 Broncho is designed to work with Ambu’s own viewer systems, but hospitals already using mixed fleets of monitors and stacks will want to test how smoothly it plugs into their existing workflow. That includes cable routing, number of free power outlets and where the monitor lives on the ward.

Respiratory therapists report that having a small, dedicated aScope setup on a wheeled cart near the ICU nursing station makes urgent procedures less chaotic. They roll the cart in, connect suction, and start, instead of hunting for a reusable scope locked in a cupboard.

Clinical impressions so far

Early adopters describe image quality as clean and sharp enough for routine bronchoscopy and secretion clearance, even though single-use optics still trail high-end reusable platforms in resolution. For most bedside procedures, staff care more about availability on demand than marginal gains in detail.

There is a sobering trade-off. Pulling a used scope off the cart and dropping it straight into a waste bin feels almost wrong to clinicians trained to protect expensive equipment. Yet for infection control, that uncompromising end-of-life is exactly the point.

Where it fits in Ambu’s portfolio

The aScope 4 Broncho sits alongside Ambu’s other single-use endoscopy lines in urology, ENT and GI, giving the company a broader installed base of monitors and a common design language. That modular thinking makes it easier for hospitals to add additional single-use scopes later.

Ambu’s strategy is to sell not just the scopes but a whole ecosystem of viewers, carts and procedure kits. For investors, that raises the prospect of recurring revenue streams, but it also binds hospitals more tightly to one supplier for critical airway equipment.

Stock context in brief

All told, the aScope 4 Broncho illustrates Ambu’s bet on single-use endoscopy as a growth driver beyond traditional resuscitation bags and masks. Ambu shares (ISIN DK0060946788) are listed in Copenhagen, with trading focused on the Nasdaq Copenhagen exchange in Danish kroner.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.